Literature DB >> 31596376

Prevalence of altered total cholesterol and fractions in the Brazilian adult population: National Health Survey.

Deborah Carvalho Malta1, Celia Landman Szwarcwald2, Ísis Eloah Machado3, Cimar Azeredo Pereira4, André Willian Figueiredo4, Ana Carolina Micheletti Gomide Nogueira de Sá3, Gustavo Velasquez-Melendez1, Filipe Malta Dos Santos5, Paulo Borges de Souza Junior2, Sheila Rizzato Stopa6, Luiz Gastão Rosenfeld7.   

Abstract

OBJECTIVE: To analyze the prevalence of altered total cholesterol and fractions levels in the Brazilian population, according to biochemical data from the National Health Survey.
METHODS: A descriptive study, using data from the National Health Survey, collected between 2014 and 2015. Total cholesterol and fractions were analyzed and population prevalences of altered values according to socio-demographic variables were calculated. The cutoff points considered were: total cholesterol ≥ 200mg/dl; low-density lipoprotein LDL ≥ 130mg/dL and high-density lipoprotein HDL < 40mg/dL.
RESULTS: The prevalence of total cholesterol ≥200mg/dL in the population was 32.7%, and higher in women (35.1%). The prevalence of altered HDL was 31.8%, 22.0% in females and 42.8% in males. LDL ≥ 130mg/dL was found in 18.6% and was higher in women (19.9%). The population aged 45 years old and older and those with low levels of education presented a higher prevalence of altered cholesterol.
CONCLUSION: Altered values of total cholesterol and fractions were frequent in the Brazilian population, especially among women, the elderly and people with low levels of education. These results may guide control and preventative actions such as healthy eating, physical activity and treatment, all of which aim to prevent coronary diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31596376     DOI: 10.1590/1980-549720190005.supl.2

Source DB:  PubMed          Journal:  Rev Bras Epidemiol        ISSN: 1415-790X


  6 in total

1.  Cardiovascular Statistics - Brazil 2021.

Authors:  Gláucia Maria Moraes de Oliveira; Luisa Campos Caldeira Brant; Carisi Anne Polanczyk; Deborah Carvalho Malta; Andreia Biolo; Bruno Ramos Nascimento; Maria de Fatima Marinho de Souza; Andrea Rocha De Lorenzo; Antonio Aurélio de Paiva Fagundes Júnior; Beatriz D Schaan; Fábio Morato de Castilho; Fernando Henpin Yue Cesena; Gabriel Porto Soares; Gesner Francisco Xavier Junior; Jose Augusto Soares Barreto Filho; Luiz Guilherme Passaglia; Marcelo Martins Pinto Filho; M Julia Machline-Carrion; Marcio Sommer Bittencourt; Octavio M Pontes Neto; Paolo Blanco Villela; Renato Azeredo Teixeira; Roney Orismar Sampaio; Thomaz A Gaziano; Pablo Perel; Gregory A Roth; Antonio Luiz Pinho Ribeiro
Journal:  Arq Bras Cardiol       Date:  2022-01       Impact factor: 2.000

2.  National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 3.  Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey.

Authors:  Jose Rocha Faria-Neto; Carlos Yarleque; Luiz Fernando Vieira; Eliane Naomi Sakane; Raul D Santos
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

4.  Prevalence, awareness, treatment, and control of dyslipidemia and associated factors among adults in Jordan: Results of a national cross-sectional survey in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Prev Med Rep       Date:  2022-06-27

5.  Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study.

Authors:  Lei Hong; Yu Han; Chunfeng Deng; Aihua Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-10-09       Impact factor: 2.174

6.  Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study.

Authors:  Yu An; Xiaona Zhang; Ying Wang; Yushan Wang; Wen Liu; Tao Wang; Zhongsheng Qin; Rong Xiao
Journal:  Mol Neurodegener       Date:  2019-12-30       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.